Blood tests to find signs of active cardiac sarcoidosis
Studies blood exosomes for markers of disease activity in people with cardiac sarcoidosis.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
- Status
- Recruiting
- People taking part
- 115 people, planned
- Started
- 13 Jul 2026
- Expected to end
- Jul 2028
- Type of study
- Observational
- Treatments tested
- Exosome Analysis
- Record updated
- 17 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults sent to the Cardiac Sarcoid Clinic because cardiac sarcoidosis (an inflammatory disease of the heart) is suspected or already confirmed. Blood samples will be studied to find markers of disease activity.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Suspected or previously confirmed cardiac sarcoidosis, active or inactive
- Biomarker or test result
- People must be having an FDG-PET scan as part of their standard care.
Main reasons for not taking part
- Not able to give informed consent
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adults ≥18 years
- Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis
- Undergoing FDG-PET as part of standard care
- Ability to provide informed consent
Who cannot take part
- Inability to provide informed consent
Where in United States
- Mayo Clinic in RochesterRochester, United StatesContact: Anna PickTaking people
About the trial
What the trial wants to find out
The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.
The group in the trial
- Cardiac Sarcoidosis Patients
Patients with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
Treatment: Exosome Analysis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
- Plain-language title
- Blood tests to find signs of active cardiac sarcoidosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 August 2026